Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

MolecularBreeding molecular evolution technology regulatory update

August 28, 2000 7:00 AM UTC

MAXY received U.S. Patent No. 6,096,548 covering the use of its directed evolution technology to develop viral vectors with enhanced ability to target specific cells. The company said targeted viruses...